Filing Details
- Accession Number:
- 0001195055-10-000001
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-07-29 13:00:00
- Reporting Period:
- 2010-07-27
- Filing Date:
- 2010-07-29
- Accepted Time:
- 2010-07-29 17:38:48
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 887708 | Caraco Pharmaceutical Laboratories Ltd | CPD | Pharmaceutical Preparations (2834) | 382505723 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1195055 | N Jitendra Doshi | 1150 Elijah Mccoy Drive Detroit MI 48202 | Chief Executive Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2010-07-27 | 10,246 | $6.04 | 38,254 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2010-07-27 | 400 | $6.05 | 37,854 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2010-07-27 | 600 | $6.06 | 37,254 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2010-07-27 | 854 | $6.07 | 36,400 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2010-07-28 | 5,700 | $6.04 | 30,700 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2010-07-29 | 1,000 | $6.04 | 29,700 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2010-07-29 | 300 | $6.05 | 29,400 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2010-07-29 | 1,200 | $6.06 | 28,200 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2010-07-29 | 400 | $6.07 | 27,800 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2010-07-29 | 300 | $6.08 | 27,500 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2010-07-29 | 100 | $6.10 | 27,400 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 26,500 | Indirect | By wife |
Footnotes
- On June 11, 2010, the reporting person entered into a Rule 10b-5 trading plan to sell up to 45,000 shares of common stock for estate and tax planning purposes. The reported sales were effected pursuant to such Rule 10b5-1 trading plan.
Billionaire Hedge Funds
